drugset / Trial / NCT03559114

PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)

NCT03559114

RandomizedParallel-groupTriple-blindPrevention

Summary

This is a phase III, multi-centre, double blind, randomized controlled trial of patients with traumatic brain injury (TBI).

Timeline

Start
2018-07-19
Primary completion
2026-12
Completion
2027-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dalteparin sodium Other / unclassified 5000 iu Subcutaneous